no code implementations • 23 Aug 2023 • John Ho, Zhao-Heng Yin, Colin Zhang, Nicole Guo, Yang Ha
Predicting the solubility of given molecules remains crucial in the pharmaceutical industry.
no code implementations • 29 Jul 2023 • Colin Zhang, Yang Ha
Sphingosine-1-phosphate receptor 1, or S1PR1, is a protein target for MS. Siponimod, a ligand of S1PR1, was approved by the FDA in 2019 for MS treatment, but there is a demonstrated need for better therapies.